Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Tools & Technology › Sequencing › Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines

Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines

Sep 23, 2019
|
Turna Ray
Premium

NEW YORK – A new international survey of experts involved in the care of cancer patients suggests that the incorporation of molecular testing is lagging in lung cancer around the world due to a variety of factors, especially cost. 

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Apr
27
Featured Webinar

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Jun
08
Featured Webinar

Advancing Personalized Oncology with Transcriptomic Profiling and Mechanistic Modeling

Sponsored by
Qiagen

Cancer is a complex and heterogeneous disease requiring patient-specific molecular analysis to support treatment decisions.

Jun
16
Featured Webinar

Precision Oncology in Melanoma Patients Treated with Immunotherapy: Clinical and Technological Perspective

Sponsored by
Biognosys

This webinar, the second in our Next-Generation Proteomics for Precision Oncology series, will discuss how unbiased discovery proteomics can be used to identify new key mechanisms and signatures supporting clinical decision-making for melanoma patients.

Jun
18
Featured Webinar

Disparities in Precision Oncology: Identifying Barriers and Moving Toward Solutions

Sponsored by
Canexia Health

Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019. 

What's Popular?

In Cancer

  1. AACR Study of Eli Lilly's Retevmo Shows Anti-Tumor Activity Across Cancers

  2. Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

    Premium

  3. Tecentriq Response Analysis in MyPathway Study Bolsters Case for Higher TMB Cutoff

    Premium

  4. Cancer Dx Firm C2i Genomics Raises $100M in Financing

  5. Carisma Therapeutics Taps Into Innate Immune System to Extend CAR Therapy to Solid Tumors

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.